Enrollment for Phase 2 Amyotrophic Lateral Sclerosis Trial is Complete
According to a story from BioSpace, the biopharmaceutical company Clene Nanomedicine, Inc., has recently announced that it has completed the process of enrollment patient participants in its upcoming phase 2…